- Investing Ideas
- Swedish Biotech Breakthroughs
Swedish Biotech Breakthroughs
Results
11
Biotech stocks worldwide which are expected to become profitable in the next 3 years.
11 companies
Ascelia Pharma
Market Cap: SEK 380.6m
A biotech company, develops identifies, develops, and commercializes novel drugs to treat orphan oncology treatments in Sweden.
ACE
SEK 3.00
7D
-0.7%
1Y
3.4%
Elicera Therapeutics
Market Cap: SEK 275.2m
A clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden.
ELIC
SEK 5.67
7D
4.8%
1Y
143.3%
Devyser Diagnostics
Market Cap: SEK 1.3b
Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.
DVYSR
SEK 77.80
7D
-1.8%
1Y
-23.0%
Guard Therapeutics International
Market Cap: SEK 30.9m
A clinical-stage biotechnology company, identifies and develops medicines to treat kidney diseases in Sweden.
GUARD
SEK 1.53
7D
-1.3%
1Y
-89.9%
Lipigon Pharmaceuticals
Market Cap: SEK 3.4m
A clinical-stage pharmaceutical company, develops drugs for lipid related diseases in Sweden.
LPGO
SEK 0.0056
7D
-30.0%
1Y
-98.1%
Active Biotech
Market Cap: SEK 117.0m
A biotechnology company, engages in the research, development, and production of pharmaceutical products in Sweden.
ACTI
SEK 0.044
7D
10.4%
1Y
-53.1%
Biovica International
Market Cap: SEK 106.8m
A biotech company, develops and commercializes novel blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in the European Union, United States of America, and internationally.
BIOVIC B
SEK 0.37
7D
-8.5%
1Y
-62.9%
FluoGuide
Market Cap: SEK 645.8m
A clinical stage biotechnology company, develops drugs for precision cancer surgery in Denmark.
FLUO
SEK 39.50
7D
14.5%
1Y
1.2%
Medivir
Market Cap: SEK 1.3b
A pharmaceutical company, focuses on the development and commercialization of treatments for cancer in Sweden, the Nordic region, rest of Europe, and internationally.
MVIR
SEK 2.40
7D
6.7%
1Y
72.7%
Vitrolife
Market Cap: SEK 12.2b
Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.
VITR
SEK 90.00
7D
-1.9%
1Y
-45.5%
SynAct Pharma
Market Cap: SEK 969.9m
A clinical stage biotechnology company, researches and develops medicines for the treatment of inflammatory diseases in Sweden.
SYNACT
SEK 17.32
7D
0%
1Y
11.7%